Skip to main content
Top

03-04-2018 | Quality of life | Article

Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach

Journal: Rheumatology and Therapy

Authors: Finbar O’Shea, Peter C. Taylor, Gavin Dickie, Andrew Yaworsky, Benjamin Banderas, Sumesh Kachroo

Publisher: Springer Healthcare

Abstract

Introduction

To establish clinical consensus on important and relevant quality-of-care (QoC) attributes in rheumatic disease (RD) treatment that may improve treatment outcomes and guide best practices.

Methods

Twenty-three QoC attributes were identified in a literature review. Fifteen European-based clinicians were selected based on their contributions to RD guidelines, publications, and patient care. A three-round (an interview round and two web-based rounds) modified Delphi panel was conducted to reach consensus and finalize a QoC attribute list.

Results

In round 1 (clinician interviews), clinicians reported 52 unique QoC attributes across 14 themes, with the greatest number of attributes reported in the “treatment goals” (n = 7) and “remote monitoring” (n = 7) themes. During rounds 2 and 3, the critically important QoC attributes most frequently reported were access to care/treatment (n = 14, 93.3%), safety of treatment (round 2 n = 14, 93.3%, round 3 n = 13, 86.7%), and access to clinicians and specialists (round 2: n = 13, 86.7%, round 3: n = 14, 93.3%). The final list contained 53 QoC attributes.

Conclusion

The study demonstrates consensus across several themes of QoC. Quality of care is a complex, multidimensional, and fluid concept that can be improved by ensuring patients have access to care, open communication between patients and clinicians, and the use of novel strategies, such as remote monitoring. Utilization of the attribute list can potentially improve the lives of patients, provide clinicians with tools to provide greater QoC, and improve the healthcare system as a whole.

Funding

Merck & Co., Inc.
Literature
1.
Guidelines for the management of rheumatoid arthritis. 2002 Update. Arthritis Rheum. 2002;46(2):328–46.CrossRef
2.
Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379–90.CrossRefPubMed
3.
Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.CrossRefPubMed
4.
Amherd-Hoekstra A, Naher H, Lorenz HM, Enk AH. Psoriatic arthritis: a review. JDDG. 2010;8(5):332–9.CrossRefPubMed
5.
Sevrain M, Villani AP, Rouzaud M, Barnetche T, Paul C, Richard MA, et al. Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international guidelines. JEADV. 2014;28(Suppl 5):33–9.PubMed
6.
Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001;45(2):151–8.CrossRefPubMed
7.
van Genderen S, van den Borne C, Geusens P, van der Linden S, Boonen A, Plasqui G. Physical functioning in patients with ankylosing spondylitis: comparing approaches of experienced ability with self-reported and objectively measured physical activity. J Clin Rheumatol. 2014;20(3):133–7.CrossRefPubMed
8.
Sandıkçı SC, Özbalkan Z. Fatigue in rheumatic diseases. Eur J Rheumatol. 2015;2(3):109–13.CrossRefPubMedPubMedCentral
9.
Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004;22(2 Suppl 1):1–12.CrossRefPubMed
10.
Martindale J, Shukla R, Goodacre J. The impact of ankylosing spondylitis/axial spondyloarthritis on work productivity. Best Pract Res Clin Rheumatol. 2015;29(3):512–23.CrossRefPubMed
11.
Haroon N, Kim TH, Inman RD. NSAIDs and radiographic progression in ankylosing spondylitis: bagging big game with small arms? Ann Rheum Dis. 2012;71(10):1593–5.
12.
Lee S, Lee SW, Song Y, Sung IH, Kim TH. Intraarticular sacroiliac corticosteroid injections in ankylosing spondylitis (abstract). Arthritis Rheumatol 2015;67(Suppl 10).
13.
Kumar A, Marwaha V. New therapies for rheumatoid arthritis. Med J Armed Forces India 2003;59(2):90–92.
14.
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(2):14–7.
15.
Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896–904.CrossRefPubMedPubMedCentral
16.
Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–50.CrossRefPubMed
17.
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(1):1–25.
18.
World Health Organization. Quality of care: a process for making strategic choices in health systems. Geneva: WHO; 2006.
19.
Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol. 2002;14(2):121–6.CrossRefPubMed
20.
van den Akker-van Marle ME, Chorus AM, Vliet Vlieland TP, van den Hout WB. Cost of rheumatic disorders in the Netherlands. Best Pract Res Clin Rheumatol. 2012;26(5):721–31.CrossRefPubMed
21.
Office of Behavioral & Social Sciences Research. Defining quality of care 2016. Available from: http://​www.​esourceresearch.​org/​eSourceBook/​EvaluatingtheQua​lityofHealthCare​/​3DefiningQuality​ofCare/​tabid/​797/​Default.​aspx#LiveContent[Sec3Ref1. Accessed 15 March 2016.
22.
Aletaha D, Alasti F, Smolen JS. Chronicity of rheumatoid arthritis affects the responsiveness of physical function, but not of disease activity measures in rheumatoid arthritis clinical trials. Ann Rheum Dis. 2015;74(3):532–7.CrossRefPubMed
23.
Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15.CrossRefPubMed
24.
Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al. Rheumatology outcomes: the patient’s perspective. J Rheumatol. 2003;30(4):880–3.PubMed
25.
MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA. 2000;284(8):984–92.CrossRefPubMed
26.
Sixma HJ, Kerssens JJ, Campen CV, Peters L. Quality of care from the patients’ perspective: from theoretical concept to a new measuring instrument. Health Expect. 1998;1(2):82–95.CrossRefPubMedPubMedCentral
27.
Jacobi CE, Boshuizen HC, Rupp I, Dinant HJ, van den Bos GA. Quality of rheumatoid arthritis care: the patient’s perspective. Int J Qual Health Care. 2004;16(1):73–81.CrossRefPubMed
28.
Dalkey N, Helmer O. An experimental application of the Delphi method to the use of experts. Manage Sci. 1963;9(3):458–67.CrossRef
29.
Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010;16(1):125–33.CrossRefPubMed
30.
Brook RH, McGlynn EA, Shekelle PG. Defining and measuring quality of care: a perspective from US researchers. Int J Qualit Health Care. 2000;12(4):281–95.CrossRef
31.
Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260(12):1743–8.CrossRefPubMed
32.
Celler BG, Lovell NH, Basilakis J. Using information technology to improve the management of chronic disease. Med J Aust. 2003;179(5):242–6.PubMed
33.
Baumgart DC. Personal digital assistants in health care: experienced clinicians in the palm of your hand? Lancet. 2005;366(9492):1210–22.CrossRefPubMed
34.
Grainger R, Townsley H. Apps for people with rheumatoid arthritis to monitor their disease activity: a review of apps for best practice and quality. JMIR Mhealth Uhealth. 2017;5(2):e7.
35.
van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, et al. Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools. RMD Open. 2016;2(2):e000302.
36.
Salaffi F, Carotti M, Ciapetti A, Di Carlo M, Gasparini S, Farah S, et al. Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach. BMC Musculoskelet Disord. 2016;17(1):146.CrossRefPubMedPubMedCentral
37.
El Miedany Y, El Gaafary M, Youssef S, Bahlas S, Almedany S, Ahmed I, et al. Toward electronic health recording: evaluation of electronic patient-reported outcome measures system for remote monitoring of early rheumatoid arthritis. J Rheumatol. 2016;43(12):2106–12.CrossRefPubMed
38.
Jayasena R, Cellar B, Sparks R, Varnfield M, Li J, Nepal S. Monitoring of chronic disease in the community: Australian telehealth study on organisational challenges and economic impact. Int J Integr Care. 2016;16(6):A106.
39.
Omer T. Empowered citizen ‘health hackers’ who are not waiting. BMC Med. 2016;14(1):118.CrossRefPubMedPubMedCentral
40.
Ridic G, Gleason S, Ridic O. Comparisons of health care systems in the United States, Germany and Canada. Mater Sociomed. 2012;24(2):112–20.CrossRefPubMedPubMedCentral